Study: Cannabis May Provide Treatment Option for Parkinson’s Disease

Cannabis may help in the treatment of Parkinson’s Disease, according to a new study published in the journal Neurotherapeutics and published online by the U.S. National Institute of Health.

“Previous studies suggest that the endocannabinoid system plays an important role in the neuropathological basis of Parkinson’s disease (PD)”, begin’s the study’s abstract. “This study was designed to detect potential alterations in the cannabinoid receptors CB1 (CB1r) and CB2 (A isoform, CB2Ar), and in monoacylglycerol lipase (MAGL) gene expression in the substantia nigra (SN) and putamen (PUT) of patients with PD.”

According to researchers, the results of the present study “suggest that CB1r, CB2r, and MAGL are closely related to the neuropathological processes of PD.” Therefore, “the pharmacological modulation of these targets [such as through the consumption of cannabis] could represent a new potential therapeutic tool for the management of PD.”

Read moreStudy: Cannabis May Provide Treatment Option for Parkinson’s Disease

Study: Cannabis May Treat Parkinson’s Disease and Other Movement Disorders

Cannabis have be an effective treatment option for those with Parkinson’s disease and other movement disorders, according to a new study published in the journal Molecular Psychiatry.

“Cannabis and related compounds have recently been studied as promising therapeutic agents in treatment of neurodegenerative and movement disorders including Parkinson’s disease”, begins the study’s abstract. “In this review we have examined the potential benefits of medical marijuana and cannabinoids in the treatment of both motor and nonmotor symptoms as well as in slowing the progression of the disease. We have looked into any scientific evidence that indicates the potential use of marijuana and/or related compounds for the treatment of PD.”

According to researchers; “Current treatments of PD provide only relief of motor symptoms and are associated with adverse effects such as dyskinesia. In addition, these therapies do not slow the progression of the disease.” Therefore, “there is an urgent need for safer drugs that can treat both motor and nonmotor symptoms of PD as well as drugs that slow the progression of the disease.”

Read moreStudy: Cannabis May Treat Parkinson’s Disease and Other Movement Disorders

Nebraska Judiciary Committee Votes to Legalize Medical Marijuana

Nebraska’s Judiciary Committee has passed legislation to legalize medical marijuana.

Legislative Bill 622 was passed by the Judiciary Committee with a 6 to 1 vote, with Senator Stebe Halloran casting the sole “No” vote. The measure allows those with a qualifying condition to possess and use marijuana medicines if they receive a recommendation from a physician and become licensed with the state. A system of regulated marijuana dispensaries would be authorized.

Qualifying conditions would include opioid addiction, AIDS, epilepsy, glaucoma, Crohn’s disease, Tourette’s syndrome, hepatitis C, lupus, Parkinson’s disease, Lyme disease, spinal cord injury or disease, post traumatic stress disorder (PTSD) and anxiety.

Read moreNebraska Judiciary Committee Votes to Legalize Medical Marijuana

Florida Officials Begin Issuing Medical Marijuana Cards to Patients

Florida’s Office of Compassionate Use has officially started issuing medical marijuana cards to patients and caregivers.

florida medical marijuanaAccording to Mara Gambinieri, spokesperson for the state’s Department of Health, their Office of Compassionate Use began processing patient applications once the state’s new medical marijuana rules took effect on February 19th.

Under the state’s law, those with a qualifying condition who receive a recommendation from a physician to use medical marijuana can apply with the department to do so. Qualifying conditions include HIV/AIDS, cancer, epilepsy, glaucoma, post traumatic stress disorder (PTSD), multiple sclerosis, Parkinson’s disease, chronic muscle spasms, amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease) and Crohn’s disease.

Read moreFlorida Officials Begin Issuing Medical Marijuana Cards to Patients

New Hampshire Governor Signs Medical Cannabis Expansion Bill

newsone.comNew Hampshire Governor Maggie Hassan has signed into law legislation that adds epilepsy, Parkinson’s disease and lupus to the state’s list of qualifying medical cannabis conditions. The measure takes effect in 60 days.

House Bill 476 adds epilepsy, lupus and Parkinson’s disease to the list of conditions that qualify someone to become a legal medical cannabis patients. Current qualifying conditions include cancer, HIV/AIDS, muscular dystrophy, Crohn’s disease, amyotrophic lateral sclerosis (ALS), glaucoma, chronic pancreatitis, spinal cord injury or disease, multiple sclerosis and traumatic brain injuries.

Read moreNew Hampshire Governor Signs Medical Cannabis Expansion Bill

Parkinson’s Patients Report Subjective Relief From Cannabis, Finds New Study

By Paul Armentano, NORML

AURORA, CO — Patientsparkinsons with Parkinson’s self-report cannabis to be a highly efficacious alternative medicine in the treatment of the disease, according to survey data published online ahead of print in the journal Evidence-Based Complimentary and Alternative Medicine.

Investigators reported that cannabis use remains comparatively uncommon among patients with Parkinson’s disease. However, those respondents who acknowledged using the plant rated it as one of the “most effective” alternative treatment therapies available.

Read moreParkinson’s Patients Report Subjective Relief From Cannabis, Finds New Study

Tennessee House Committee Passes Medical Cannabis Legalization Bill

A proposalmedicanna to legalize the use of cannabis-based medicines for those with a recommendation from a physician has been approved with a unanimous vote by Tennessee’s House Health Subcommittee. The full committee is expected to begin discussing the bill next week.

If approved into law, the proposal – sponsored by Representative Ryan Williams (R-Cookeville) – would allow those with stage II, III or IV terminal cancer, Parkinson’s disease, multiple sclerosis, Huntington’s disease and certain forms of epilepsy to possess and use cannabis pills or patches, if they receive a recommendation from a physician and register with the Tennessee Department of Health. Unfortunately dried cannabis flower will remain illegal even for medical use.

Read moreTennessee House Committee Passes Medical Cannabis Legalization Bill

Bill to Allow Medical Use of Cannabis Extracts Passes Idaho Senate Committee

Cannabis tincture.
Cannabis tincture.

Idaho’s Senate State Affairs Committee has approved an amended version of Senate Bill 1146, a proposal to allow for the possession and use of low-THC cannabis extracts for medical purposes.

The proposal, which is sponsored by Senator Curt McKenzie, Chairman of the Senate State Affairs Committee, was approved narrowly with a 5 to 4 vote.

Senate Bill 1146 would allow those with ailments such as cancer, Parkinson’s disease and epilepsy who receive a recommendation from a physician to use cannabis extracts that have low amounts of THC (tetrahydrocannabinol).

Read moreBill to Allow Medical Use of Cannabis Extracts Passes Idaho Senate Committee

Study: CBD Administration Associated with Improved Quality of Life in Patients with Parkinson’s Disease

By Paul Armentano, NORML

The administration of cannabidiol (CBD), a nonpsychotropic cannabinoid, is associated with improved quality of life in patients with Parkinson’s diseasecbd, according clinical trial data published online ahead of print in the Journal of Psychopharmacology.

Investigators at the University of São Paulo in Brazil assessed the efficacy of CBD versus placebo in 21 subjects with Parkinson’s. Authors reported that the administration of 300 mg doses of CBD per day was associated with “significantly different mean total scores” in subjects’ well-being and quality of life compared to placebo.

Read moreStudy: CBD Administration Associated with Improved Quality of Life in Patients with Parkinson’s Disease

Study: Cannabidiol Can Control Symptoms of REM Sleep Behavior Disorder

A study published by the Journal of Clinical Pharmacy and Therapeutics has found that cannabidiol (CBD), a compound found in cannabisrem, can control the symptoms of REM sleep behavior disorder (RBD) in those with Parkinson’s disease.

“Cannabidiol (CBD) is the main non-psychotropic component of the Cannabis sativa plant”, explains researchers. “REM sleep behaviour disorder (RBD) is a parasomnia characterized by the loss of muscle atonia during REM sleep associated with nightmares and active behaviour during dreaming. We have described the effects of CBD in RBD symptoms in patients with Parkinson’s disease.”

Read moreStudy: Cannabidiol Can Control Symptoms of REM Sleep Behavior Disorder